Homepage 2018-05-16T23:22:20+00:00

Latest Updates from GI Logic

Doctors are testing this ‘Fitbit for the stomach’ to help patients lose weight

November 25th, 2017|

(CNBC) -- Doctors at Cedars-Sinai Hospital in Los Angeles are testing out a new wearable called "AbStats," that can read the stomach in a similar manner to how a Fitbit tracks steps.

Alpha Logic Inc. Announces Research Collaboration with GlaxoSmithKline

June 23rd, 2017|

Strategic agreement to conduct groundbreaking, wordwide research on the use of the AbStats system for tracking and treating people with chronic irregularity and irritable bowel syndrome (IBS).

Alpha Logic Inc. Announces Strategic Investment from Commonwealth Diagnostics International

August 16th, 2016|

Investment will facilitate the launch the FDA Cleared AbStats system to key hospitals and gastroenterologists.

FDA Approves Use of UCLA-created Wearable Device to Address Gastrointestinal Disorders

January 11th, 2016|

The U.S. Food and Drug Administration has cleared the use of a device invented at UCLA that could improve care for patients with gastrointestinal problems.

See all our latest news

‘Fitbit for the stomach’ featured on CNBC

AbStats featured on CNBCCNBC highlights how our easy-to-use, non-invasive and reliable digestive telemetry system, AbStats, can be useful to help patients lose weight and recover from surgeries more quickly.


The Sensor Revolution

Fitbit, Moto360, Apple Watch — our lives are being transformed by wearable tech. The same technology will transform healthcare. One of our principal investigators explains how.

Doctor Pimmentel

Abstats – The New Vital Sign®

In gastroenterology there is no noninvasive monitoring tool besides the stethoscope, which was invented in 1816. AbStats aims to change that. Find out how from our researchers.